ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2015 to Q4 2025

Type / Class: Equity / COM NEW
Symbol: AVXL on Nasdaq
Price per share: $3.56
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 32,467,128
Total reported value: $289,450,105
% of total 13F portfolios: 0%
Share change: -7,451
Value change: -$271,921
Number of holders: 183
Price from insider filings: $3.56

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

As of 30 Sep 2025, 183 institutional investors reported holding 32,467,128 shares of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL).

Institutional Holders of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	154,477	$556,108	+$286,326			$3.56	8
2025 Q3	32,467,128	$289,450,105	-$271,921	$9,208,020	$15,045,845	$8.90	183
2025 Q2	32,493,276	$301,726,227	+$10,099,066	$6,954,646	$9,540,856	$9.22	175
2025 Q1	31,369,737	$269,176,514	+$13,007,772	$5,259,114	$10,248,616	$8.58	178
2024 Q4	29,547,094	$316,161,065	+$29,473,787	$8,282,478	$9,645,648	$10.74	167
2024 Q3	26,968,911	$153,149,572	-$533,003	$4,476,976	$2,926,904	$5.68	142
2024 Q2	26,760,101	$112,930,616	-$18,825,367	$3,209,310	$2,843,014	$4.22	135
2024 Q1	30,948,610	$157,506,940	+$27,304,520	$6,610,892	$4,629,355	$5.09	140
2023 Q4	25,832,104	$240,513,953	+$8,316,479	$19,885,603	$6,463,933	$9.31	146
2023 Q3	25,058,666	$164,128,831	-$1,892,057	$7,652,293	$5,627,760	$6.55	140
2023 Q2	25,281,347	$205,636,828	-$14,163,807	$4,749,893	$4,958,426	$8.13	143
2023 Q1	27,108,237	$232,269,844	+$393,430	$7,989,985	$11,077,368	$8.57	139
2022 Q4	27,002,000	$250,064,092	+$22,831,014	$23,390,070	$9,920,558	$9.26	136
2022 Q3	24,372,403	$251,469,999	-$6,293,663	$19,182,000	$9,179,000	$10.32	139
2022 Q2	24,888,142	$249,199,961	-$1,729,547	$16,440,500	$6,559,000	$10.01	142
2022 Q1	24,991,414	$307,685,297	+$32,689,444	$7,680,000	$13,013,000	$12.31	131
2021 Q4	22,100,211	$383,138,229	+$25,372,466	$12,996,692	$14,980,000	$17.34	142
2021 Q3	20,580,263	$369,399,670	-$25,050,093	$12,974,000	$12,751,000	$17.95	131
2021 Q2	21,526,442	$492,165,210	+$81,312,363	$27,891,000	$26,147,000	$22.86	124
2021 Q1	18,187,562	$271,803,006	+$79,133,906	$7,300,000	$10,223,000	$14.95	101
2020 Q4	13,964,886	$75,410,516	+$6,571,033	$1,813,000	$1,280,000	$5.40	88
2020 Q3	12,684,452	$57,699,630	+$3,160,613	$1,385,000	$583,000	$4.55	75
2020 Q2	11,946,714	$58,843,561	+$1,942,364	$2,117,000	$313,000	$4.92	74
2020 Q1	11,691,929	$36,823,316	-$5,016,089	$1,562,000	$78,000	$3.15	65
2019 Q4	13,916,000	$36,043,597	+$1,117,491	$1,098,000	$195,000	$2.59	59
2019 Q3	13,289,318	$41,993,556	+$4,737,912	$1,116,000	$288,000	$3.16	54
2019 Q2	11,767,055	$39,650,063	+$14,871,644	$746,000	$186,000	$3.37	55
2019 Q1	7,377,719	$22,501,197	+$2,167,483	$419,000	$51,000	$3.05	51
2018 Q4	6,715,415	$10,473,190	-$2,650,363	$338,000	$38,000	$1.56	44
2018 Q3	8,213,369	$22,311,576	-$2,312,830	$875,000	$184,000	$2.73	44
2018 Q2	9,088,737	$23,812,662	-$3,161,313	$512,000	$87,000	$2.62	52
2018 Q1	10,279,544	$28,366,015	+$325,912	$388,000	$94,000	$2.76	53
2017 Q4	10,135,530	$32,634,077	+$289,125	$425,000	$103,000	$3.22	56
2017 Q3	10,036,457	$41,546,671	-$980,609	$4,262,000	$182,000	$4.14	60
2017 Q2	10,290,140	$54,735,640	+$4,823,505	$6,239,000	$377,000	$5.32	56
2017 Q1	9,371,190	$53,788,000	+$19,419,492	$6,962,000	$517,000	$5.74	53
2016 Q4	7,507,035	$29,724,887	+$11,510,670	$5,724,000	$136,000	$3.96	58
2016 Q3	4,582,303	$16,628,382	+$2,565,105	$963,000	$288,000	$3.63	51
2016 Q2	3,826,280	$23,378,725	+$10,539,944	$989,000	$553,000	$6.11	44
2016 Q1	2,161,346	$10,589,000	+$3,670,757	$286,000	$328,000	$4.90	39
2015 Q4	1,369,818	$7,628,000	+$7,625,000	$302,000	$1,160,000	$5.57	28